Treatment of HIVAN involves mostly ART, angiotensin-converting enzyme inhibitors (ACEi), and steroids, with the goal of slowing HIV-1 replication and the progression of kidney disease. This evidence concerns the gene ACE and HIV-associated nephropathy.